Literature DB >> 9257296

Drugs from the sea: harvesting the results of aeons of chemical evolution.

R W Wallace.   

Abstract

Despite the recent development of combinatorial chemistry for the rapid generation of thousands of new chemicals, the pharmaceutical industry still looks to the natural environment to uncover novel compounds that extend the boundaries of our chemical imagination. The terrestrial environment has been mined for such compounds for many years with great success. Now the world's oceans are beginning to yield hidden treasures. Many of these chemicals are structurally complex, stretching the prowess of modern organic chemists to their limits as they attempt to mimic the synthetic versatility of nature. In the future, these marine compounds are likely to yield entirely new classes of drugs that will be a valuable contribution to our ability to treat human disease.

Entities:  

Mesh:

Year:  1997        PMID: 9257296     DOI: 10.1016/S1357-4310(97)01059-9

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  6 in total

1.  Cytotoxic cyplasin of the sea hare, Aaplysia punctata, cDNA cloning, and expression of bioactive recombinants in insect cells.

Authors:  Christian Petzelt; Gaby Joswig; Hermann Stammer; Dieter Werner
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

2.  CAM, eCAM, Bioprospecting: The 21st Century Pyramid.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2005-06       Impact factor: 2.629

3.  Drug Discovery, CAM and Natural Products.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2004-12       Impact factor: 2.629

4.  The immune system and complementary and alternative medicine.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2007-09       Impact factor: 2.629

5.  Traditional and Modern Biomedical Prospecting: Part I-the History: Sustainable Exploitation of Biodiversity (Sponges and Invertebrates) in the Adriatic Sea in Rovinj (Croatia).

Authors:  Werner E. G. Müller; Renato Batel; Heinz C. Schröder; Isabel M. Müller
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

6.  Commentary on Traditional and Modern Biomedical Prospecting: Part II-The Benefits by Werner E.G. Muller, Heinz C. Schroder, Matthias Wiens, Sanja Perovic-Ottstadt, Renato Batel and Isabel M. Muller: Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.